Skip to main content
. 2023 Oct 30;10:1250340. doi: 10.3389/fcvm.2023.1250340

Figure 1.

Figure 1

From multi-omics approaches to personalized medicine in myocardial infarction. Genomics, epigenomics, transcriptomics, proteomics, metabolomics, and other omics technologies can be used to detect and analyze tissue or body fluid (such as blood, urine, and saliva) samples from MI patients. Omics and multi-omics approaches offer a wide range of applications in advancing precision medicine, encompassing biomarker discovery, drug target identification, patient stratification, and predicting drug responses. The part of the figure is drawn with the pictures of Servier Medical Art (https://smart.servier.com).